Passage Bio, Inc.PASGNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +12.96% | +10.33% | +2.75% | +2.62% | +2.25% |
| Weighted Average Shares Diluted Growth | +12.96% | +10.33% | +2.75% | +2.62% | +2.25% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -31.97% | -38.80% | -36.84% | -33.64% | -39.19% |
| Book Value per Share Growth | -51.26% | -59.64% | -58.88% | -58.29% | -70.06% |
| Debt Growth | -3.11% | -5.14% | -5.43% | -5.74% | -5.75% |
| R&D Expense Growth | -21.40% | -32.93% | -44.26% | -50.24% | -43.31% |
| SG&A Expenses Growth | -36.47% | -6.60% | -30.57% | -40.04% | +23.27% |